☆ 4.5 Editorial Material

Opportunities and challenges in the design of selective TAAR1 agonists: an editorial

EXPERT OPINION ON THERAPEUTIC PATENTS (2018)

Get Full Text
Add to Collection

Journal

EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 28, Issue 6, Pages 437-440

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/13543776.2018.1476493

Keywords

TAAR1; agonists; thyronamine; drug design; GPCR; perspective

Categories

Chemistry, Medicinal Pharmacology & Pharmacy

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.